Suzanne L. Sexton, PA-C, MMS Expert Witness
Curriculum Vitae


Contact Information

  • Phone: (520) 305-0338
Email this expert

Specialties & Experience

General Specialties: Physician Assistant and Urology & Urological Surgery

Specialty Focus: Physician Assistant, Advanced Practice Provider, urology, general urology, advanced prostate cancer, urinary incontinence, retention, neurogenic bladder, BPH, UTI, prostate cancer, bladder cancer, prostatectomy, TURP, post-op, cystoscopy, PA, midlevel

Education: Bachelor of Science, Truman State University; Master of Medical Science in Physician Assistant Studies, Midwestern University-Glendale

Years in Practice: 12

Additional Information

I have been a board-certified Physician Assistant since 2007, with 10 years of experience practicing general urology. I have a strong background in clinical management and multidisciplinary care coordination. To succeed in my work, I stay current on the most recent advances in urology/urologic oncology. This includes attending conferences, reading current journals, reviewing published studies, and discussing advances in treatment protocols with colleagues, industry representatives and thought leaders in these areas. I am also actively involved in staff training, student precepting and patient education. Areas of expertise: -Identifying complications vs. known risk factors associated w/ common urologic surgeries and in-office urology procedures, including Rezum and Urolift for enlarged prostate, cystoscopy, and prostate biopsy. -Management of common urologic conditions and standard of care for a Physician Assistant in urology -More efficiently review hospital / office / operating room records to determine merit or causation in urologic cases. -Identification of causation related to side effects from medications commonly prescribed for urologic conditions such as urinary tract infections and erectile dysfunction. -Assessment of post-operative complications, such as blood clots or infection due to failure to meet appropriate post-operative standard of care. -Identify improper management of low T (hypogonadism) patients, particularly in free-standing men's health clinics. -Evaluate if appropriate algorithms were followed in the diagnosis, treatment and management of patients w/ prostate cancer. -Help to identify causation of neurogenic bladder (urinary incontinence or retention) or erectile dysfunction as a result of spinal cord/pelvic injury from MVA, trauma, fall, etc. -Determine risk factors of possible advancing disease due to the nationwide shortage of BCG for treatment of bladder cancer over the past year.